FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000956507> ?p ?o ?g. }

• W2000956507 endingPage "188" @default.
• W2000956507 startingPage "181" @default.
• W2000956507 abstract "Eldecalcitol (ELD), a 2β-hydroxypropyloxy derivative of 1α,25 (OH) 2D3, inhibits bone resorption more potently than alfacalcidol (ALF) while maintaining osteoblastic function in an ovariectomized (OVX) osteoporosis rat model. Alendronate (ALN), which is the most common bisphosphonate used for the treatment of osteoporosis, increases the bone mineral density (BMD) by suppressing bone resorption. In this study, we investigated the effects of combination treatments with ELD and ALN or with ALF and ALN on bone mass and strength in OVX rats. Seventy female rats, 32 weeks old, were assigned to seven groups: (1) a sham-operated control group; (2) an OVX-control group; (3) an ELD group; (4) an ALF group; (5) an ALN group; (6) an ELD+ALN group; and (7) an ALF+ALN group. OVX rats were orally treated with ELD (0.015 μg/kg), ALF (0.0375 μg/kg), or ALN (0.2mg/kg) daily for 12 weeks. In both the lumbar spine and the femur, ELD and ALF monotherapy significantly increased the BMD, and ELD+ALN and ALF+ALN significantly increased the BMD, compared with ALN monotherapy, as an additive effect. In particular, ELD+ALN resulted in a significantly higher BMD than ALF+ALN in the femur. On mechanical testing of the lumbar spine, ELD and ALF monotherapy significantly increased the ultimate load, and ELD+ALN and ALF+ALN significantly increased the ultimate load compared with ALN monotherapy. In the femur, ELD, ELD+ALN, and ALF+ALN treatment significantly increased the ultimate load, compared with the OVX-control group, and ELD+ALN resulted in a significantly higher ultimate load than ALN monotherapy. A histomorphometric analysis showed that ELD monotherapy and ELD+ALN combination therapy had a potent inhibitory effect on bone resorption parameters (osteoclast surface and eroded surface), while maintaining bone formation parameters (osteoblast surface and osteoid surface). By contrast, ALF and ALF+ALN significantly lowered the histological parameters of both bone resorption and formation. These results suggested that ELD or ALF used in combination with ALN has therapeutic advantages over ALN monotherapy, with ELD+ALN combination treatment producing an especially beneficial anti-osteoporotic effect by inhibiting osteoclastic bone resorption and maintaining osteoblastic function, compared with ALF+ALN combination treatment." @default.
• W2000956507 created "2016-06-24" @default.
• W2000956507 creator A5030793371 @default.
• W2000956507 creator A5044825939 @default.
• W2000956507 creator A5052700281 @default.
• W2000956507 creator A5055851227 @default.
• W2000956507 date "2013-01-01" @default.
• W2000956507 modified "2023-09-23" @default.
• W2000956507 title "Effects of combined treatment with eldecalcitol and alendronate on bone mass, mechanical properties, and bone histomorphometry in ovariectomized rats: A comparison with alfacalcidol and alendronate" @default.
• W2000956507 cites W1973707842 @default.
• W2000956507 cites W1974744779 @default.
• W2000956507 cites W1981595493 @default.
• W2000956507 cites W1999438656 @default.
• W2000956507 cites W2005298224 @default.
• W2000956507 cites W2019693617 @default.
• W2000956507 cites W2023781848 @default.
• W2000956507 cites W2031519620 @default.
• W2000956507 cites W2034913902 @default.
• W2000956507 cites W2036608246 @default.
• W2000956507 cites W2038415173 @default.
• W2000956507 cites W2048873273 @default.
• W2000956507 cites W2056017178 @default.
• W2000956507 cites W2056717809 @default.
• W2000956507 cites W2057112909 @default.
• W2000956507 cites W2074890088 @default.
• W2000956507 cites W2081964827 @default.
• W2000956507 cites W2081971996 @default.
• W2000956507 cites W2087378917 @default.
• W2000956507 cites W2094514334 @default.
• W2000956507 cites W2094538032 @default.
• W2000956507 cites W2098782984 @default.
• W2000956507 cites W2107131674 @default.
• W2000956507 cites W2107789045 @default.
• W2000956507 cites W2118968952 @default.
• W2000956507 cites W2139196426 @default.
• W2000956507 cites W2144971094 @default.
• W2000956507 cites W2314110838 @default.
• W2000956507 cites W2314255836 @default.
• W2000956507 cites W2321227665 @default.
• W2000956507 cites W2783103906 @default.
• W2000956507 doi "https://doi.org/10.1016/j.bone.2012.09.031" @default.
• W2000956507 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23041510" @default.
• W2000956507 hasPublicationYear "2013" @default.
• W2000956507 type Work @default.
• W2000956507 sameAs 2000956507 @default.
• W2000956507 citedByCount "18" @default.
• W2000956507 countsByYear W20009565072013 @default.
• W2000956507 countsByYear W20009565072014 @default.
• W2000956507 countsByYear W20009565072015 @default.
• W2000956507 countsByYear W20009565072016 @default.
• W2000956507 countsByYear W20009565072017 @default.
• W2000956507 countsByYear W20009565072018 @default.
• W2000956507 countsByYear W20009565072019 @default.
• W2000956507 countsByYear W20009565072021 @default.
• W2000956507 crossrefType "journal-article" @default.
• W2000956507 hasAuthorship W2000956507A5030793371 @default.
• W2000956507 hasAuthorship W2000956507A5044825939 @default.
• W2000956507 hasAuthorship W2000956507A5052700281 @default.
• W2000956507 hasAuthorship W2000956507A5055851227 @default.
• W2000956507 hasConcept C126322002 @default.
• W2000956507 hasConcept C126894567 @default.
• W2000956507 hasConcept C134018914 @default.
• W2000956507 hasConcept C141071460 @default.
• W2000956507 hasConcept C2776541429 @default.
• W2000956507 hasConcept C2776886416 @default.
• W2000956507 hasConcept C2777164284 @default.
• W2000956507 hasConcept C2777251235 @default.
• W2000956507 hasConcept C2779126354 @default.
• W2000956507 hasConcept C2779809032 @default.
• W2000956507 hasConcept C2780554211 @default.
• W2000956507 hasConcept C2911223091 @default.
• W2000956507 hasConcept C673006 @default.
• W2000956507 hasConcept C71924100 @default.
• W2000956507 hasConcept C8264082 @default.
• W2000956507 hasConceptScore W2000956507C126322002 @default.
• W2000956507 hasConceptScore W2000956507C126894567 @default.
• W2000956507 hasConceptScore W2000956507C134018914 @default.
• W2000956507 hasConceptScore W2000956507C141071460 @default.
• W2000956507 hasConceptScore W2000956507C2776541429 @default.
• W2000956507 hasConceptScore W2000956507C2776886416 @default.
• W2000956507 hasConceptScore W2000956507C2777164284 @default.
• W2000956507 hasConceptScore W2000956507C2777251235 @default.
• W2000956507 hasConceptScore W2000956507C2779126354 @default.
• W2000956507 hasConceptScore W2000956507C2779809032 @default.
• W2000956507 hasConceptScore W2000956507C2780554211 @default.
• W2000956507 hasConceptScore W2000956507C2911223091 @default.
• W2000956507 hasConceptScore W2000956507C673006 @default.
• W2000956507 hasConceptScore W2000956507C71924100 @default.
• W2000956507 hasConceptScore W2000956507C8264082 @default.
• W2000956507 hasIssue "1" @default.
• W2000956507 hasLocation W20009565071 @default.
• W2000956507 hasLocation W20009565072 @default.
• W2000956507 hasOpenAccess W2000956507 @default.
• W2000956507 hasPrimaryLocation W20009565071 @default.
• W2000956507 hasRelatedWork W2000956507 @default.
• W2000956507 hasRelatedWork W2020365883 @default.
• W2000956507 hasRelatedWork W2030818130 @default.
• W2000956507 hasRelatedWork W2067532042 @default.

• next